-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Informed Consent for Genetic Testing in Hematology

Program: Education Program
Session: Genetic Testing for Heritable Hematologic Disorders 101
Hematology Disease Topics & Pathways:
Adult, Diseases, Bone Marrow Failure, Elderly, Genetic Disorders, Pediatric, Pregnancy, Technology and Procedures, Young Adult, Lymphoid Malignancies, Study Population, Myeloid Malignancies, genetic profiling, Clinically relevant, Quality Improvement , molecular testing, newborn screening, NGS, RNA sequencing, WGS
Monday, December 7, 2020, 1:25 PM-1:30 PM

Jonathan M Marron, MD, MPH

Pediatric Oncology, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Office of Ethics, Children's Hospital Boston/dana-Farber Cancer Institute, Boston, MA; Center for Bioethics, Harvard Medical School, Boston, MA

Disclosures: No relevant conflicts of interest to declare.

See more of: Genetic Testing for Heritable Hematologic Disorders 101
See more of: Education Program
<< Previous Presentation | Next Presentation